| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/23/2009 | DE202008003335U1 Pharmazeutische Zusammensetzung zur Behandlung und Prophylaxe der Migräne A pharmaceutical composition for the treatment and prophylaxis of migraine |
| 07/23/2009 | DE102008005484A1 Induktion und Förderung der Arteriogenese Induction and promotion of arteriogenesis |
| 07/23/2009 | CA2713365A1 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same |
| 07/23/2009 | CA2712443A1 6- and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | CA2712276A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 07/23/2009 | CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712256A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/23/2009 | CA2712195A1 Method for treating addiction using quercetin-containing compositions |
| 07/23/2009 | CA2712141A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/23/2009 | CA2711977A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/23/2009 | CA2711931A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | CA2711655A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | CA2711520A1 Bifeprunox derivatives |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080760A1 Fused quinoline derivative and use thereof |
| 07/22/2009 | EP2080519A1 Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor |
| 07/22/2009 | EP2079847A1 Peptides containing tryptophan |
| 07/22/2009 | EP2079737A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
| 07/22/2009 | EP2079735A1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
| 07/22/2009 | EP2079734A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 07/22/2009 | EP2079730A1 Mglur5 modulators |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079693A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 07/22/2009 | EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/22/2009 | EP2079526A1 Compositions and uses thereof in the treatment of wounds |
| 07/22/2009 | EP2079485A2 Phenylpropionamide compounds and the use thereof |
| 07/22/2009 | EP2079453A1 Robust sustained release formulations |
| 07/22/2009 | EP1877052B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/22/2009 | EP1605040B1 Monocyte-origin multipotent cell momc |
| 07/22/2009 | EP1542981B1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1458413B1 Pharmaceutical compositions based on azetidine derivatives |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1443053B1 Analgesic antitumor peptide from scorpion and method of producing it |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1220689B1 Medicament for the treatment of chronic fatigue syndrome associated with fibromyalgia and irritable bowel syndrome. |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516061C Pyridine derivatives as NMDA receptor ligands |
| 07/22/2009 | CN100516059C Remedies |
| 07/22/2009 | CN100516047C Lactam compound |
| 07/22/2009 | CN100516040C Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515486C Medicine for treating senile dementia and its preparing process |
| 07/22/2009 | CN100515440C Composition extracted from Danzhi Xiaoyao Powder and application thereof |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/21/2009 | US7563912 new improved method for manufacturing chemical intermediate of (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders; stereospecific; industrial scale production, environmentally friendly |
| 07/21/2009 | US7563903 Acylaminothiazole derivatives, their preparation and their therapeutic use |
| 07/21/2009 | US7563895 Quinoxaline compounds |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563809 Nociceptin analogs |
| 07/21/2009 | US7563808 administering a cholinesterase inhibitor ( a dimethoxyindanone derivative) to treat dementia associated with or caused by vascular diseases |
| 07/21/2009 | US7563797 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| 07/21/2009 | US7563796 8-(4-Tert-butylphenyl)-8-phenyl-2,3,4,8-tetrahydroimidazol[1, 5-a]pyrimidin-6-amine; Alzheimer's disease; treating beta-amyloid deposits and neurofibrillary tangles; Sown syndrome; dementia; neurodenerative diseases; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; cognition activators |
| 07/21/2009 | US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563785 Quetiapine analogs and methods of use thereof |
| 07/21/2009 | US7563778 Antisense oligonucleotide preparation method |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563467 Use of an Opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 07/21/2009 | CA2478393C 1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine prevention and treatment |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2409845C Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2288789C Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 07/16/2009 | WO2009089482A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | WO2009089448A1 Therapeutic disulfide compounds for treating pain and diabetes |
| 07/16/2009 | WO2009089284A2 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist |
| 07/16/2009 | WO2009089235A1 Preparation of sulfamide derivatives |
| 07/16/2009 | WO2009089210A1 Preparation of sulfamide derivatives |
| 07/16/2009 | WO2009089093A1 Thyroid hormone receptor agonists |
| 07/16/2009 | WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | WO2009089024A1 Neuroactive steroid compositions and methods of use therefor |
| 07/16/2009 | WO2009088997A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | WO2009088530A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | WO2009088314A1 Method for producing a biologically active complex exhibiting neuroregenerative and neuroprotective activity |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009087667A2 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
| 07/16/2009 | WO2009087615A1 Pharmaceutical compositions and methods utilizing a d-amino acid and an antioxidant for treating neuropsychiatric disorders |
| 07/16/2009 | WO2009087568A2 Compositions comprising antioxidant and mitoprotective flavonoids with neuroprotective properties |
| 07/16/2009 | WO2009087564A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
| 07/16/2009 | WO2009087361A1 Microvesicles |
| 07/16/2009 | WO2009087351A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 07/16/2009 | WO2009087305A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 07/16/2009 | WO2009087285A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | WO2009087238A2 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | WO2009087220A1 Use of thiazoloimidazoles, thiazolotetrazoles and thiazolotriazoles as mglur5 antagonists |
| 07/16/2009 | WO2009087218A1 Thiazoltriazoles and thiazolimidazoles as antagonists of the mglur5 receptor |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |